Sofinnova Partners

Summary

Sofinnova Partners appeared to be the VC, which was created in 1972. The company was established in Europe in France. The leading representative office of defined VC is situated in the Paris.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - France. We can highlight the next thriving fund investment areas, such as Health Care, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Addex Therapeutics, DBV Technologies, MedDay. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little.

Besides them, we counted 11 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Sofinnova Partners, startups are often financed by Gimv, Idinvest Partners, Bpifrance. The meaningful sponsors for the fund in investment in the same round are Seventure Partners, Idinvest Partners, Auriga Partners. In the next rounds fund is usually obtained by Gimv, Andera Partners, Venrock.

This Sofinnova Partners works on 5 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2010. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 7-12 deals every year. The average startup value when the investment from Sofinnova Partners is 10-50 millions dollars. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies.